Europe appears on the verge of a mezzanine revival.
Exponent Private Equity, a UK mid-market firm founded in 2004, has closed its second fund with commitments of £805 million ( €1 billion; $1.6 billion). The fund is double the amount raised in the first fund in 2004. Investors included funds managed by Pathway, Pantheon Ventures, Danske Private Equity, MassPRIM, OMERS Capital Partners, NYL Capital Partners and Bank of Scotland, as well as substantial US endowment and European private family sources. Hugh Richards, one of the firm's four founding partners, answers PEI's questions.
PERE looks back at the year just passed for the trends that mattered most. Today we look at trend number nine - London broke records in 2007 for the most expensive property ever sold. Were the sellers calling the top of the market?
The spin-out from 3i is profiting from investor appetite for mid-market deals as the credit crunch hits large buyouts.
PERE looks back at the year just passed for the trends that mattered most. Today we look at trend number nine - London broke records in 2007 for the most expensive property ever sold. Were the sellers calling the top of the market?
The spin-out from 3i is profiting from investor appetite for mid-market deals as the credit crunch hits large buyouts.
Connecticut-based Drum Capital, led by Scott Vollmer, will commit capital to distressed debt, turnaround and restructuring funds.
Connecticut-based Drum Capital, led by Scott Vollmer, will commit capital to distressed debt, turnaround and restructuring funds.
Asia Alternatives goes large * China sovereign fund dampens foreign fears * Dubai's HBG nears $200m target * Ex-Temasek executives fundraising for China * First close for Sharia vehicle on $200m * Aureos backed by Kazakhstan FoF
Guido Gamucci is chairman of Permira's operation in Asia. Previously responsible for the firm's Milan office, he relocated to Japan in 2005 and is poised to move to Hong Kong when the UK buyout group opens its second office in the region next year. In October, Permira made headlines for doing not just one, but two large deals in Asia. First came an $838 million investment for a 20 percent stake in Galaxy Entertainment, a Macau-based casino operator; then followed a $2.2 billion secondary deal to acquire Arysta Lifescience, a Japanese agrochemical company, from Olympus Capital. For Permira, it was the first investment in Japan since its arrival two years ago.